Part of UT Health San Antonio
A pilot study to evaluate the chemopreventive effects of epigallocatechin gallate (EGCG) in colorectal cancer (CRC) patients with curative resections (CTMS# 16-0085)
To evaluate the preventive effects of EGCG on colonic tissue in patients with resected colorectal cancer when compared to patients on observation.
Type of Cancer Treated
- University Hospital Health System
- UT Health Science Center